HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention
HTG Highlights the Advantages of Its Drug Discovery Engine
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights
HTG Provides Update on Drug Discovery Partnering Initiative
HTG Announces Key First Quarter Milestone Achievements for Drug Discovery
HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19
HTG Provides a Year-End Update on its Drug Discovery Business and Attends LifeSci Partners 2023 Corporate Access Event
HTG Announces Certain Preliminary 2022 Unaudited Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.